Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,700 | 402 | 99.8% |
| Education | $17.71 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,273 | 109 | $0 (2024) |
| Lilly USA, LLC | $1,314 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,129 | 67 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $609.73 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $461.68 | 30 | $0 (2023) |
| Merck Sharp & Dohme LLC | $444.38 | 34 | $0 (2022) |
| Amarin Pharma Inc. | $234.52 | 14 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $170.85 | 8 | $0 (2022) |
| Exact Sciences Corporation | $153.81 | 7 | $0 (2024) |
| ABBVIE INC. | $121.19 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $893.62 | 42 | Lilly USA, LLC ($248.87) |
| 2023 | $856.74 | 45 | Lilly USA, LLC ($248.82) |
| 2022 | $1,119 | 57 | Lilly USA, LLC ($426.93) |
| 2021 | $1,113 | 54 | Novo Nordisk Inc ($302.76) |
| 2020 | $747.61 | 43 | Novo Nordisk Inc ($194.14) |
| 2019 | $993.39 | 58 | Novo Nordisk Inc ($468.43) |
| 2018 | $1,064 | 56 | Novo Nordisk Inc ($544.18) |
| 2017 | $929.95 | 49 | Novo Nordisk Inc ($387.99) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.88 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $5.61 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | SERVIER PHARMACEUTICALS LLC | Voranigo (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Oncology | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: DIABETES | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $31.71 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Oncology | ||||||
| 07/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.91 | General |
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: DIABETES | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Gastroenterology | ||||||
| 05/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 823 | 1,150 | $225,081 | $64,672 |
| 2022 | 13 | 1,060 | 1,377 | $263,153 | $77,632 |
| 2021 | 12 | 1,120 | 1,518 | $298,808 | $88,443 |
| 2020 | 13 | 1,145 | 1,561 | $317,688 | $90,525 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 155 | 155 | $55,490 | $21,865 | 39.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 158 | $48,335 | $9,410 | 19.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 112 | 154 | $31,724 | $7,715 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 71 | 106 | $42,930 | $7,029 | 16.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 75 | 75 | $12,225 | $5,395 | 44.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 86 | $16,598 | $4,446 | 26.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 81 | 81 | $5,913 | $2,805 | 47.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 163 | 291 | $2,872 | $2,401 | 83.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $6,006 | $2,218 | 36.9% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 19 | 19 | $2,280 | $831.42 | 36.5% |
| 99453 | Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | Office | 2023 | 12 | 12 | $708.00 | $556.18 | 78.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 181 | 181 | $64,317 | $26,237 | 40.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 278 | $84,512 | $16,840 | 19.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 83 | $33,615 | $7,782 | 23.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 100 | 101 | $16,463 | $6,772 | 41.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 146 | $30,076 | $6,083 | 20.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 109 | 110 | $8,030 | $3,814 | 47.5% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 72 | 72 | $8,640 | $3,205 | 37.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 15 | 15 | $6,930 | $2,870 | 41.4% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 35 | 35 | $3,620 | $1,616 | 44.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 179 | 307 | $2,456 | $900.06 | 36.6% |
| 0004A | Adm sarscov2 30mcg/0.3ml bst | Office | 2022 | 15 | 15 | $1,800 | $686.70 | 38.2% |
| 0013A | Adm sarscov2 100mcg/0.5ml3rd | Office | 2022 | 11 | 12 | $1,220 | $558.65 | 45.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 20 | 22 | $1,474 | $266.87 | 18.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 209 | 209 | $67,089 | $30,957 | 46.1% |
About Dr. Carlos Covarrubias Ponce, MD
Dr. Carlos Covarrubias Ponce, MD is a Family Medicine healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1306839469.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carlos Covarrubias Ponce, MD has received a total of $7,717 in payments from pharmaceutical and medical device companies, with $893.62 received in 2024. These payments were reported across 404 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($7,700).
As a Medicare-enrolled provider, Covarrubias Ponce has provided services to 4,148 Medicare beneficiaries, totaling 5,606 services with total Medicare billing of $321,273. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Silver Spring, MD
- Active Since 08/24/2005
- Last Updated 03/26/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1306839469
Products in Payments
- FARXIGA (Drug) $1,049
- Ozempic (Drug) $831.77
- JARDIANCE (Drug) $604.74
- Tresiba (Drug) $482.23
- MOUNJARO (Drug) $473.48
- TRULICITY (Drug) $446.05
- JANUVIA (Drug) $294.55
- Vascepa (Drug) $234.52
- TOUJEO (Drug) $212.68
- TRADJENTA (Drug) $206.95
- Rybelsus (Drug) $205.86
- RYBELSUS (Drug) $200.75
- Victoza (Drug) $180.42
- Cologuard Collection Kit (Device) $153.81
- Saxenda (Drug) $150.02
- HETLIOZ (Drug) $149.57
- Xultophy 100/3.6 (Drug) $130.88
- BELSOMRA (Drug) $121.00
- Dexcom G5 Mobile CGM System (Device) $115.41
- SOLIQUA 100/33 (Biological) $104.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Silver Spring
Dr. Jean Welsh, Md, MD
Family Medicine — Payments: $29,783
Adolph Johnson, M.d, M.D
Family Medicine — Payments: $13,149
Dr. Mark Major, M.d, M.D
Family Medicine — Payments: $9,878
Mrs. Shelley Williams, M.d, M.D
Family Medicine — Payments: $7,163
Dr. Wendy Wong, M.d, M.D
Family Medicine — Payments: $5,757
Maria Martin, M.d, M.D
Family Medicine — Payments: $4,746